Show Notes for September 2018 – Episode 24

*

Association between portosystemic shunts and increased complications and mortality in patients with cirrhosis  – Gastro

*

Safety and efficacy of elobixibat for chronic  constipation–  The Lancet: Gastro

*

Oral Anticoagulation in Patients With Liver Disease – JACC

*

Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases – Gastro

*

Risk of Oral and Upper GI cancer in FIT-positive Colorectal cancer screening program. – CGH

*

Extraintestinal Manifestations in Vedolizumab and  Anti-TNFTreated Patients With Inflammatory Bowel Disease – IBD Journal

*

Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features – Cell

*

Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT – Cell

*

Beyond O&P Times Three – Am J Gastro

*

Helicobacter Pylori Infection Does Not Protect Against Eosinophilic Esophagitis – Am J Gastro

Tweet